Senores Pharmaceuticals Limited — Board Meeting, 27-07-2026: Outcome of Board Meeting
27-07-2026 | 03:16 pm
27-07-2026 | 03:16 pm
Senores Pharma reports robust Q1 FY27 consolidated results: Revenue at ₹180 Cr (+36% Y-o-Y) and PAT at ₹31 Cr (+56% Y-o-Y). The board also approved Ms. Anjali Shah as Senior Management Personnel. #Earnings #Pharma
No comments yet. Be the first to comment!
